Cargando…

Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany

Background: In response to the COVID-19-pandemic, a lockdown was established in the middle of March 2020 by the German Federal Government resulting in drastic reduction of private and professional traveling in and out of Germany with a reduction of social contacts in public areas. Research Questions...

Descripción completa

Detalles Bibliográficos
Autores principales: Scherbaum, Norbert, Bonnet, Udo, Hafermann, Henning, Schifano, Fabrizio, Bender, Stefan, Grigoleit, Torsten, Kuhn, Jens, Nyhuis, Peter, Preuss, Ulrich W., Reymann, Gerhard, Schneider, Udo, Shibata, Jo, Specka, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102785/
https://www.ncbi.nlm.nih.gov/pubmed/33967857
http://dx.doi.org/10.3389/fpsyt.2021.648273
_version_ 1783689174753214464
author Scherbaum, Norbert
Bonnet, Udo
Hafermann, Henning
Schifano, Fabrizio
Bender, Stefan
Grigoleit, Torsten
Kuhn, Jens
Nyhuis, Peter
Preuss, Ulrich W.
Reymann, Gerhard
Schneider, Udo
Shibata, Jo
Specka, Michael
author_facet Scherbaum, Norbert
Bonnet, Udo
Hafermann, Henning
Schifano, Fabrizio
Bender, Stefan
Grigoleit, Torsten
Kuhn, Jens
Nyhuis, Peter
Preuss, Ulrich W.
Reymann, Gerhard
Schneider, Udo
Shibata, Jo
Specka, Michael
author_sort Scherbaum, Norbert
collection PubMed
description Background: In response to the COVID-19-pandemic, a lockdown was established in the middle of March 2020 by the German Federal Government resulting in drastic reduction of private and professional traveling in and out of Germany with a reduction of social contacts in public areas. Research Questions: We seek evidence on whether the lockdown has led to a reduced availability of illegal drugs and whether subjects with substance-related problems tried to cope with possible drug availability issues by increasingly obtaining drugs via the internet, replacing their preferred illegal drug with novel psychoactive substances, including new synthetic opioids (NSO), and/or by seeking drug treatment. Methods: A questionnaire was anonymously filled in by subjects with substance-related disorders, typically attending low-threshold settings, drug consumption facilities, and inpatient detoxification wards from a range of locations in the Western part of Germany. Participants had to both identify their main drug of abuse and to answer questions regarding its availability, price, quality, and routes of acquisition. Results: Data were obtained from 362 participants. The most frequent main substances of abuse were cannabis (n = 109), heroin (n = 103), and cocaine (n = 75). A minority of participants reported decreased availability (8.4%), increased price (14.4%), or decreased quality (28.3%) of their main drug. About 81% reported no change in their drug consumption due to the COVID-19 pandemic and the lockdown. A shift to the use of novel psychoactive substances including NSO were reported only by single subjects. Only 1–2% of the participants obtained their main drug via the web. Discussion: Present findings may suggest that recent pandemic-related imposed restrictions may have not been able to substantially influence either acquisition or consumption of drugs within the context of polydrug users (including opiates) attending a range of addiction services in Germany.
format Online
Article
Text
id pubmed-8102785
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81027852021-05-08 Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany Scherbaum, Norbert Bonnet, Udo Hafermann, Henning Schifano, Fabrizio Bender, Stefan Grigoleit, Torsten Kuhn, Jens Nyhuis, Peter Preuss, Ulrich W. Reymann, Gerhard Schneider, Udo Shibata, Jo Specka, Michael Front Psychiatry Psychiatry Background: In response to the COVID-19-pandemic, a lockdown was established in the middle of March 2020 by the German Federal Government resulting in drastic reduction of private and professional traveling in and out of Germany with a reduction of social contacts in public areas. Research Questions: We seek evidence on whether the lockdown has led to a reduced availability of illegal drugs and whether subjects with substance-related problems tried to cope with possible drug availability issues by increasingly obtaining drugs via the internet, replacing their preferred illegal drug with novel psychoactive substances, including new synthetic opioids (NSO), and/or by seeking drug treatment. Methods: A questionnaire was anonymously filled in by subjects with substance-related disorders, typically attending low-threshold settings, drug consumption facilities, and inpatient detoxification wards from a range of locations in the Western part of Germany. Participants had to both identify their main drug of abuse and to answer questions regarding its availability, price, quality, and routes of acquisition. Results: Data were obtained from 362 participants. The most frequent main substances of abuse were cannabis (n = 109), heroin (n = 103), and cocaine (n = 75). A minority of participants reported decreased availability (8.4%), increased price (14.4%), or decreased quality (28.3%) of their main drug. About 81% reported no change in their drug consumption due to the COVID-19 pandemic and the lockdown. A shift to the use of novel psychoactive substances including NSO were reported only by single subjects. Only 1–2% of the participants obtained their main drug via the web. Discussion: Present findings may suggest that recent pandemic-related imposed restrictions may have not been able to substantially influence either acquisition or consumption of drugs within the context of polydrug users (including opiates) attending a range of addiction services in Germany. Frontiers Media S.A. 2021-04-23 /pmc/articles/PMC8102785/ /pubmed/33967857 http://dx.doi.org/10.3389/fpsyt.2021.648273 Text en Copyright © 2021 Scherbaum, Bonnet, Hafermann, Schifano, Bender, Grigoleit, Kuhn, Nyhuis, Preuss, Reymann, Schneider, Shibata and Specka. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Scherbaum, Norbert
Bonnet, Udo
Hafermann, Henning
Schifano, Fabrizio
Bender, Stefan
Grigoleit, Torsten
Kuhn, Jens
Nyhuis, Peter
Preuss, Ulrich W.
Reymann, Gerhard
Schneider, Udo
Shibata, Jo
Specka, Michael
Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
title Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
title_full Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
title_fullStr Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
title_full_unstemmed Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
title_short Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
title_sort availability of illegal drugs during the covid-19 pandemic in western germany
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102785/
https://www.ncbi.nlm.nih.gov/pubmed/33967857
http://dx.doi.org/10.3389/fpsyt.2021.648273
work_keys_str_mv AT scherbaumnorbert availabilityofillegaldrugsduringthecovid19pandemicinwesterngermany
AT bonnetudo availabilityofillegaldrugsduringthecovid19pandemicinwesterngermany
AT hafermannhenning availabilityofillegaldrugsduringthecovid19pandemicinwesterngermany
AT schifanofabrizio availabilityofillegaldrugsduringthecovid19pandemicinwesterngermany
AT benderstefan availabilityofillegaldrugsduringthecovid19pandemicinwesterngermany
AT grigoleittorsten availabilityofillegaldrugsduringthecovid19pandemicinwesterngermany
AT kuhnjens availabilityofillegaldrugsduringthecovid19pandemicinwesterngermany
AT nyhuispeter availabilityofillegaldrugsduringthecovid19pandemicinwesterngermany
AT preussulrichw availabilityofillegaldrugsduringthecovid19pandemicinwesterngermany
AT reymanngerhard availabilityofillegaldrugsduringthecovid19pandemicinwesterngermany
AT schneiderudo availabilityofillegaldrugsduringthecovid19pandemicinwesterngermany
AT shibatajo availabilityofillegaldrugsduringthecovid19pandemicinwesterngermany
AT speckamichael availabilityofillegaldrugsduringthecovid19pandemicinwesterngermany